Complement-mediated renal diseases

Clinical trials for Complement-mediated renal diseases explained in plain language.

Never miss a new study

Get alerted when new Complement-mediated renal diseases trials appear

Sign up with your email to follow new studies for Complement-mediated renal diseases, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

New injection shows promise for kidney disease patients

Disease control Not yet recruiting

This study tests an investigational drug called LP-005 in 46 adults with complement-mediated kidney disease, a condition where the immune system attacks the kidneys. Participants receive the injection alongside their standard care. The goal is to see if the drug can reduce protei…

Matched conditions: COMPLEMENT-MEDIATED RENAL DISEASES

Phase 2 • Sponsor: Longbio Pharma • Aim: Disease control

Last updated Jun 27, 2026 08:13 UTC

Complement-mediated renal diseases

Get alerted when new Complement-mediated renal diseases trials appear

New injection shows promise for kidney disease patients